Eledon Pharmaceuticals Inc (ELDN) Dividend History

$2.12 $-0.01

Dividend Score
Dividend Yield
0%

Annual Payment
$0

Payout Ratio
0%
Dividend Increases
0 yrs

Price Chart

Key Metrics

Sector Healthcare
Industry Biotechnology
Avg daily volume 106,964
Market cap 51,300,000
Beta 0.85
Trailing 12 Month EPS -5.44
Next Earnings Date
Ex-dividend date
P/E ratio 0

Company Description

eledon pharmaceuticals, inc. is a clinical stage biotechnology company using its expertise in targeting the cd40l pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease. our lead program, at-1501, is a potential best-in-class humanized igg1 anti-cd40l antibody with high affinity for cd40l, a well-validated biological target with broad therapeutic potential. the cd40/cd40l pathway plays a central role in generating pro-inflammatory responses in autoimmune disease, allograft transplant rejection, and neuroinflammation.

Dividend Payments

Forward Yield
0%
Forward Payment
$0

Trailing Yield
0%
Trailing Payment
$0

Last Increase
> 10 Years Ago
Last Cut
> 10 Years Ago

5 Year Average Yield
0%
Vs Current Yield
0%

5 Year Div Growth Rate
0%
Payment Frequency
-

Historical Dividend Payments